Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of PT001 in Japanese Subjects with COPD
NCT03256552Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- Jan 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Jan 2015; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03256552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256552.